55.7 F
San Diego
Tuesday, Mar 19, 2024
-Advertisement-

Venter Exits CEO Role

Craig Venter is retiring as the CEO of San Diego-based Human Longevity Inc., about five months after reassuming the role.

In December, Venter was reappointed as CEO of Human Longevity, a for-profit company he co-founded with the goal of helping people live longer and healthier lives. He replaced Cynthia Collins, who held the role for less than a year and previously was CEO of GE Healthcare.

Human Longevity’s offering Health Nucleus, a clinical research and discovery center, delivers what the company calls actionable insights into health.

“I am retiring from HLi and will be returning to the J Craig Venter Institute to continue my work,” wrote Venter on Twitter May 24.

The nonprofit genomics research institute was founded by Venter. Scientists, led by the institute, are working on a five-year project with the U.S. Department of Energy to substantially increase oil, or lipid production, in hopes of spurring next-generation biofuels and bioproducts.

What his departure means for Human Longevity isn’t clear — made even murkier by the fact that the company as of May 30 hadn’t laid out plans for a successor. Requests to Human Longevity for further information and comment went unanswered.

When reached over the phone, former Human Longevity CFO Bill Roper could only speculate.

“While I…haven’t talked to Craig since the announcement, as a scientist and researcher I suspect that the day-to-day-business activities of running a business weren’t as interesting to him as returning to research at JCVI,” said Roper, who is also president of Roper Capital Co..

Human Longevity has raised more than $300 million, including from major sources GE Ventures, Illumina and Celgene.

The company touts whole genome sequencing that analyzes a person’s entire DNA, unlike some tests that only deliver a few traits or disease risks. Human Longevity purports to shed light on many potential health issues, medications a person may respond to and ancestry links.

-Advertisement-

Featured Articles

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-